Generex Biotechnology Corp. (GNBT) is in the Pharma Industry

• Sort by

• Four Drug Companies Vying for Diabetes Patients

  R.J Steffens submits: The American Association of Diabetes Educators [AADE] released results last week at its high profile 35th Annual Meeting from an innovative new survey entitled the "Injection Impact Report". The report highlights the level of communication between patients and healthcare providers relating to insulin injections and...

  External links 2008-08-17

  Tags: Healthcare, Biotech, Generex Biotechnology Corp., Eli Lilly & Co., NUVO Network Management Inc., Sanofi-Aventis

Additional Resources

• Crystal Research Associates, LLC Issues Executive Informational Overview® on Generex Biotechnology Corporation

  NEW YORK, Aug. 20 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational OverviewR (EIOR) on Generex Biotechnology Corporation . The full 64-page report can be found at http://www.crystalra.com/. Generex Biotechnology Corporation ("Generex" or "the Company") is a specialty pharmaceutical company...

  Articles 2008-08-20

• Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC

  BOSTON, July 30 /PRNewswire/ -- Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation , entitled, "RapidMistTM, the Non-Invasive Oral Drug Delivery Platform, Sets the Tone as Best in Class Followed by an Expanding Pipeline and Global Revenues." This review is available at website: http://www.scimitarequity.com/. ...

  Articles 2008-07-30

• Generex Biotechnology Featured on FOXNews.com

  Generex Oral-lyn[TM], Oral Insulin Product, Described as a "New Tool to Help Diabetics" WORCESTER, Mass. -- Generex Biotechnology Corporation (NasdaqCM: GNBT, www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, is featured in an interview segment on FOXNews.com concerning Generex Oral-lyn[TM],...

  Articles 2008-07-23

• Generex Biotechnology Featured in the Second Flaherty Special Situations

  GNBT Leads the 80-Year-Old Marathon Race for Drug Delivery of Oral Insulin with Its Use of Absorption Through the Inner Lining of the Mouth with No Insulin Deposited in Patient Lungs WEST HARRISON, N.Y. -- Generex Biotechnology Corporation's (NASDAQ:GNBT) race to pioneer drug delivery of oral insulin through...

  Articles 2008-04-10

• BellwetherReport.com Free Analyst Review for FORM, GNBT, PTRY and NRGN

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased research on the companiesmentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have scheduled interviews with a number of the...

  Articles 2008-04-09

• Generex Awarded Patents In North And South America

  Generex Biotechnology Corporation (Nasdaq:GNBT), Worcester,Mass., has received new patents in Canada and Argentina. The Canadian Intellectual Property Office has granted the company a new patent titled, "Mixed Micellar Pharmaceutical Delivery System and Method of Preparation." The patent contains process, formulation and use claims to a mixed micellar pharmaceutical...

  Articles 2008-04-01

• Before the Bell Report for Wednesday, March 26th, 2008 - On the Radar:.

  M2 PRESSWIRE-26 March 2008-The Micro Cap Opportunity: Before the Bell Report for Wednesday, March 26th, 2008 - On the Radar:C1994-2008 M2 COMMUNICATIONS LTD RDATE:26032008 LOS ANGELES - This morning's On the Radar' Micro Cap trading candidates include, Home Solutions...

  Articles 2008-03-26

• STHG, GNBT, JUNI, PLTG - OTCStockExchange.com Stock Alert.

  M2 PRESSWIRE-26 March 2008-otcstockexchange.com: STHG, GNBT, JUNI, PLTG - OTCStockExchange.com Stock AlertC1994-2008 M2 COMMUNICATIONS LTD RDATE:26032008 Rochester, NY -- OTCStockExchange.com's "Stock Watch Alert" this morning are Steadfast Holdings Group, Inc. (Pink Sheets: STHG), Generex Biotechnology Corporation (Nasdaq: GNBT),...

  Articles 2008-03-26

• Introduces Generex Biotechnology to our Bluechips Portfolio.

  M2 PRESSWIRE-13 March 2008-Stock Target Upgrade: Introduces Generex Biotechnology to our Bluechips PortfolioC1994-2008 M2 COMMUNICATIONS LTD RDATE:13032008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the...

  Articles 2008-03-13

• Generex Biotechnology Comments on Recent Trading Activity

  Rodman & Renshaw Analyst Reiterates Market Outperform Rating and $6 Price Target WORCESTER, Mass. -- Generex Biotechnology Corporation (NasdaqCM:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, commented on trading activity in its stock. The Company believes that the decline in...

  Articles 2008-03-11

• Generex Gets Approval For Oral-Lyn Phase Iii Trial

  Generex Biotechnology Corporation (Nasdaq:GNBT), Worcester, Mass., a leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced that on January 22, 2008 the Ministry of Health of the Ukraine issued an approval letter for the conduct of a Phase III clinical trial protocol for Generex...

  Articles 2008-03-01

• Has added Generex Biotechnology Corp. to their watch list.

  M2 PRESSWIRE-15 January 2008-The Maybach Journal: Has added Generex Biotechnology Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:15012008 Maybach Financial Group is a syndicate of financial analysts, with a core group representing over 250 years of total investing...

  Articles 2008-01-15

• New Report Provides a Snapshot Version of Generex Biotechnology Corporation's Performance

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79219) has announced the addition of Generex Biotechnology Corporation - Company Profile to their offering. Company Profile will assists individual investors, managers and companies in evaluating opportunities, trends, market innovations, and selecting appropriate information solutions in order to make effective decisions. The...

  Articles 2008-01-14

• Wall Street News Alert: Breaking News Alert -- AVRG! December 4, 2007

  Wall Street News Alert's "stocks to watch" thismorning are: Advanced Resources Group (PINKSHEETS: AVRG), LDK Solar Co.,Ltd. (NYSE: LDK), Generex Biotechnology Corporation (NASDAQ: GNBT) and ZixCorporation (NASDAQ: ZIXI). The current price of gold is now trading around $800 per ounce, which meansinvestors should have Advanced Resources Group (PINKSHEETS: AVRG) on...

  Articles 2007-12-04

• Research and Markets: the New Generex Biotechnology Corporation Latest Product Pipeline Report Contains Contact Information, Business Summary, Company Details and Selected Financial Data

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c73920) has announced the addition of "Generex Biotechnology Corporation - Product Pipeline Report" to their offering. The Generex Biotechnology Corporation Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease...

  Articles 2007-11-08

• Wall Street News Alert: DMHN, Monday's Hot Stock to Watch! October 22, 2007

  Wall Street News Alert's "stocks to watch" thismorning are: Dynamic Media Holdings, Inc. (PINKSHEETS: DMHN), PMC-Sierra,Inc. (NASDAQ: PMCS), Generex Biotechnology Corporation (NASDAQ: GNBT) andIntuitive Surgical, Inc. (NASDAQ: ISRG). Having recently announced it has secured distribution with several Fortune500 companies, Dynamic Media Holdings, Inc. (PINKSHEETS: DMHN) should onceagain have investors watching...

  Articles 2007-10-22

• Stock Market Alerts: Special Alert and Coverage Issued for RBRM! September 19, 2007

  Stock Market Alerts' performance stock listincludes: ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM), GenerexBiotechnology Corp. (NASDAQ: GNBT), Medtronic, Inc. (NYSE: MDT), Novavax,Inc. (NASDAQ: NVAX). Having just announced yesterday morning it has reached $1.5 million insales, ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM) should haveinvestors monitoring the stock closely as the company made...

  Articles 2007-09-19

• European patents for Generex

  Generex Biotechnology Corporation US has been awarded new patents in Europe and Mexico. The European Patent Office granted the company its fourth European patent titled, "Proteinic Drug Delivery System using Membrane Mimetics." The patent has been validated in nine European countries including the UK, France and Italy. It contains formulation...

  Articles 2007-09-01

• Stocks to Watch - GNBT, NUVO, MNRO, VIAC.

  M2 PRESSWIRE-22 August 2007-SmallCapReview: Stocks to Watch - GNBT, NUVO, MNRO, VIACC1994-2007 M2 COMMUNICATIONS LTD RDATE:23082007 Generex Biotechnology Corporation (Nasdaq: GNBT) Closed at $1.51. Today announced that its wholly-owned subsidiary has entered into an agreement with the University of Rochester as...

  Articles 2007-08-22